A recent federal court ruling has major implications for how the IRS enforces the Affordable Care Act (ACA)’s Employer Shared Responsibility Provisions (ESRP). Employers who have been assessed ESRP penalties under the ACA may want to take a closer look.
The ruling found that the IRS exceeded its authority by assessing ESRP penalties based on certifications that should have come directly from HHS and not from the IRS. The ACA does not permit HHS to transfer the authority to issue these certifications to the IRS.
The court also said that HHS’s past attempts at issuing these certifications were inadequate. As a result, the IRS’s Letter 226-J, which typically serves as a notice to employers of an ESRP penalty liability, was found to be unsupported in this case. The court ordered a refund of over $205,000 in ESRP penalties to the employer, though it denied a request for attorney’s fees.
If your health plan has been assessed an ESRP penalty without proper certification from HHS, this decision may be relevant to you. If so, please discuss with your legal counsel.
HHS has until late June to appeal this decision. We will keep you posted on any future developments.
Related Blogs
Retirement
PUBLISHED
March 12th, 2026
530A Accounts (“Trump Accounts”) — Summary as of 3/5/2026
Scott T. Bilyou
What Is a 530A / Trump Account? A new type of individual retirement account for children under age 18, created under the One Big ...
Read More
Retirement
PUBLISHED
March 10th, 2026
A Retirement Plan Spring-Cleaning Checklist
Hayden Hunter
Spring is right around the corner, and I’m not about to ask you to clear out closets or face whatever has collected behind your ...
Read More
Employee Benefits
PUBLISHED
February 20th, 2026
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn Deck
The Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
Benefits+
PUBLISHED
February 10th, 2026
Employer Response to Pharma Shifts
Chris Antypas
Volatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
Benefits+
PUBLISHED
February 9th, 2026
White House Launches TrumpRx, Unveils Drug Prices
DeAnn Deck
On Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
Benefits+
PUBLISHED
February 6th, 2026
DOL Issues Updated Model Employer CHIP Notice
DeAnn Deck
The U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More